(-0.03%) 5 467.89 points
(0.15%) 39 171 points
(0.17%) 17 748 points
(0.00%) $80.83
(-5.04%) $2.62
(-0.85%) $2 310.90
(-0.24%) $28.80
(3.13%) $1 017.30
(0.31%) $0.936
(0.76%) $10.68
(0.51%) $0.792
(-0.28%) $87.25
0.00% $ 7.12
Live Chart Being Loaded With Signals
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments...
Stats | |
---|---|
Volumen de hoy | 0 |
Volumen promedio | 747 281 |
Capitalización de mercado | 156.51M |
EPS | $-0.840 ( Q3 | 2022-11-10 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-3.89 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.459 (6.45%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-03-08 | Kayitalire Louis | Sell | 29 236 | Common Stock |
2023-03-08 | Kayitalire Louis | Sell | 25 019 | Common Stock |
2023-03-08 | Kayitalire Louis | Sell | 27 289 | Stock Option (right to buy) |
2023-03-08 | Kayitalire Louis | Sell | 12 880 | Stock Option (right to buy) |
2023-03-08 | Kayitalire Louis | Sell | 53 634 | Stock Option (right to buy) |
INSIDER POWER |
---|
-97.82 |
Last 100 transactions |
Buy: 1 523 682 | Sell: 2 468 516 |
Volumen Correlación
F-star Therapeutics, Inc. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
F-star Therapeutics, Inc. Correlación - Moneda/Commodity
F-star Therapeutics, Inc. Finanzas
Annual | 2021 |
Ingresos: | $21.17M |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1.517 |
FY | 2021 |
Ingresos: | $21.17M |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1.517 |
FY | 2020 |
Ingresos: | $11.26M |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-9.69 |
FY | 2019 |
Ingresos: | $28.32M |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-2.54 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
F-star Therapeutics, Inc.
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company\'s principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing first-in-human clinical study of FS222, a bispecific antibody that is in Phase 1 clinical trial targeting the costimulatory CD137 receptor and the inhibitory PD-L1 ligand. In addition, the company is also evaluating FS120 and SB 11285 for patients with advanced cancers, which are under Phase 1 clinical trials. F-star Therapeutics, Inc. was incorporated in 2002 and is headquartered in Cambridge, the United Kingdom.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico